Glucotrack, Inc. Increase (Decrease) in Accounts Payable
Glucotrack, Inc. (GCTK) reported Increase (Decrease) in Accounts Payable of -$201.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- Glucotrack, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$183.00K, a 117.73% decline year-over-year.
- Glucotrack, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$18.00K, a 102.90% decline year-over-year.
- Glucotrack, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$392.00K.
- Glucotrack, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$935.00K.
- Glucotrack, Inc. increase (decrease) in accounts payable for fiscal 2025 was $325.00K, a 23.57% increase from fiscal 2024.
- Glucotrack, Inc. increase (decrease) in accounts payable for fiscal 2024 was $263.00K, a 57.49% increase from fiscal 2023.
- Glucotrack, Inc. increase (decrease) in accounts payable for fiscal 2023 was $167.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$201.00K 10-Q · filed 2026-08-14 | -$593.00K derived: sum of 3 quarters · filed 2026-08-14 | -$1.53M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$18.00K 10-Q · filed 2026-05-14 | -$410.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.34M derived: sum of 3 quarters · filed 2026-05-14 | -$313.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.33M derived: sum of 2 quarters · filed 2026-03-30 | -$295.00K derived: sum of 3 quarters · filed 2026-08-14 | $325.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$935.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $97.00K derived: sum of 2 quarters · filed 2026-08-14 | $717.00K 10-Q · filed 2025-11-13 | -$149.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.65M 10-Q · filed 2026-08-14 | $786.00K derived: sum of 3 quarters · filed 2026-08-14 | $18.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $620.00K 10-Q · filed 2026-05-14 | -$246.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.01M derived: sum of 3 quarters · filed 2026-05-14 | $708.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.63M derived: sum of 2 quarters · filed 2026-03-30 | $88.00K derived: sum of 3 quarters · filed 2026-03-30 | $263.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$768.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $954.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.13M 10-Q · filed 2025-11-13 | $698.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.90M 10-Q · filed 2025-08-14 | $1.47M derived: sum of 3 quarters · filed 2025-08-14 | $1.89M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $175.00K 10-Q · filed 2025-05-14 | -$256.00K derived: sum of 2 quarters · filed 2025-05-14 | $169.00K derived: sum of 3 quarters · filed 2025-05-14 | $355.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$6.00K derived: sum of 2 quarters · filed 2025-03-31 | $180.00K derived: sum of 3 quarters · filed 2025-03-31 | $167.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $425.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $611.00K derived: sum of 2 quarters · filed 2024-11-14 | $598.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $173.00K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | -$13.00K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |